← Leaderboards
Laura J Sim-Selley
Virginia Commonwealth University
$4,975,714
Attributed
$10,134,592
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,134,592 · 5
By mechanism
R01$10,015,057 · 4
K01$119,535 · 1
Top collaborators
- Sidney S Negus9 shared
- Dana E Selley9 shared
- Kurt Francis Hauser6 shared
- Aron H Lichtman6 shared
- Mohamad Imad Damaj3 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Aron H Lichtman$10,846,349
- Sylvia Fitting$5,745,457
- Joel Evan Schlosburg$1,052,043
- S Murthy Karnam$10,390,734
- William A Devane$273,141
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBehaviorReceptorAgonistPainGtp-Binding ProteinsG-Protein-Coupled ReceptorsMediatingDown-RegulationChronicAcuteDesensitizationDepressed MoodBrainProtein ActivationNeuronsCannabinoidsGeneticAnalgesicsAbsence Of Pain SensationLigandsPlaySiteBase
Grant awards (26)
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms$626,434
R01 · FY2025 · CA
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms$598,671
R01 · FY2024 · CA
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms$613,882
R01 · FY2023 · CA
Endocannabinoid modulation of pain-depressed behavior$490,537
R01 · FY2020 · DA · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$541,645
R01 · FY2019 · NS · contact PI
Endocannabinoid modulation of pain-depressed behavior$490,537
R01 · FY2019 · DA · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$500,578
R01 · FY2018 · NS · contact PI
Endocannabinoid modulation of pain-depressed behavior$489,758
R01 · FY2018 · DA · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$411,286
R01 · FY2018 · NS · contact PI
Endocannabinoid modulation of pain-depressed behavior$534,072
R01 · FY2017 · DA · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$484,727
R01 · FY2017 · NS · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$475,313
R01 · FY2016 · NS · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$396,661
R01 · FY2015 · NS · contact PI
Endocannabinoid modulation of pain-depressed behavior$331,329
R01 · FY2015 · DA
Endocannabinoid modulation of pain-depressed behavior$336,375
R01 · FY2014 · DA
Endocannabinoid modulation of pain-depressed behavior$322,920
R01 · FY2013 · DA
Endocannabinoid modulation of pain-depressed behavior$336,375
R01 · FY2012 · DA
Endocannabinoid modulation of pain-depressed behavior$318,555
R01 · FY2011 · DA
Brain Cannabinoid Signaling: Selectivity and Adaptation$296,689
R01 · FY2010 · DA · contact PI
Brain Cannabinoid Signaling: Selectivity and Adaptation$299,000
R01 · FY2009 · DA · contact PI
Brain Cannabinoid Signaling: Selectivity and Adaptation$219,713
R01 · FY2006 · DA · contact PI
Brain Cannabinoid Signaling: Selectivity and Adaptation$225,000
R01 · FY2005 · DA
Brain Cannabinoid Signaling: Selectivity and Adaptation$225,000
R01 · FY2004 · DA
Brain Cannabinoid Signaling: Selectivity and Adaptation$225,000
R01 · FY2003 · DA
Brain Cannabinoid Signaling: Selectivity and Adaptation$225,000
R01 · FY2002 · DA
LOCALIZATION OF RECEPTOR ACITIVITY FOR DRUGS OF ABUSE$119,535
K01 · FY2000 · DA